Molecular mechanism of GANT61 combined with doxorubicin in the treatment of gliomas based on network pharmacology

被引:0
作者
Chen, Jing [1 ]
Zhang, Qiang [1 ]
Zhuang, Yuandong [1 ]
Liu, Shuang [1 ]
Zhou, Xi [1 ]
Zhang, Guoliang [1 ]
机构
[1] Fujian Med Univ, Dept Neurosurg, Union Hosp, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China
关键词
Apoptosis; Glioma; Chemotherapy; Doxorubicin; GANT61; Network pharmacology; Molecular mechanism; Pathway; Proliferation; Targeted therapy; Tumor; INDUCED DIFFERENTIATION; DOWN-REGULATION; EXPRESSION; PROLIFERATION; PROGNOSIS; EFFICACY; PROTEIN;
D O I
10.1016/j.ejbt.2021.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Gliomas are common malignant intracranial tumors. Efficacious targeted therapy against gliomas is lacking. Results: GANT61 combined with the chemotherapy drug doxorubicin for treatment of glioma (LN-229) cells, and the effect of their combination, was tested. The molecular mechanism was explored by target prediction, along with functional analysis using the Gene Ontology (GO) database, enrichment analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, construction of protein-protein interaction (PPI) networks, and protein expression. Combination of GANT61 plus doxorubicin could inhibit the growth of LN-229 cells effectively. Wound-healing data and expression of migration proteins related to epithelial-to-mesenchymal transition showed that this combination could inhibit the migration of LN-229 cells. Sixty-one targets of drug and disease intersected. Functional analysis revealed negative regulation of apoptosis, positive regulation of cell proliferation, and other biological processes related to apoptosis and proliferation. Pathway-enrichment analysis showed drug combination to be related to the cyclic adenosine monophosphate signaling pathway, pathways in cancer, and Hedgehog signaling pathway. Measurement of expression of several proteins related to these pathways revealed expression of BIRC5, GLi1 and GLi2, MMP3 and MMP9 proteins to decrease, and expression of MDM2 and P53 proteins to decrease and increase, respectively. Conclusions: This study provides a: (a) new direction for targeted therapy of gliomas; (b) theoretical basis for drug research and molecular-mechanism research on gliomas. How to cite: Chen J, Zhang Q, Zhang G et al. Molecular mechanism of GANT61 combined with doxorubicin in the treatment of gliomas based on network pharmacology. Electron J Biotechnol 2021;55. https://doi.org/10.1016/j.ejbt.2021.11.001. (c) 2021 Pontificia Universidad Catolica de Valparaiso. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:18 / 26
页数:9
相关论文
共 35 条
[1]   The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy [J].
Armas-Lopez, Leonel ;
Zuniga, Joaquin ;
Arrieta, Oscar ;
Avila-Moreno, Federico .
ONCOTARGET, 2017, 8 (36) :60684-60703
[2]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[3]   GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma [J].
Borah, Ankita ;
Pillai, Sindhu C. ;
Rochani, Ankit K. ;
Palaninathan, Vivekanandan ;
Nakajima, Yoshikata ;
Maekawa, Toru ;
Kumar, D. Sakthi .
NANOTECHNOLOGY, 2020, 31 (18)
[4]  
Chaturvedi Nagendra K, 2018, Oncotarget, V9, P16619, DOI 10.18632/oncotarget.24618
[5]   United States Food and Drug Administration drug approval summary: Gefitinib (ZD1839; Iressa) tablets [J].
Cohen, MH ;
Williams, GA ;
Sridhara, R ;
Chen, G ;
McGuinn, WD ;
Morse, D ;
Abraham, S ;
Rahman, A ;
Liang, CY ;
Lostritto, R ;
Baird, A ;
Pazdur, R .
CLINICAL CANCER RESEARCH, 2004, 10 (04) :1212-1218
[6]  
Gao Shi-yong, 2020, Chinese Pharmacological Bulletin, V36, P1209, DOI 10.3969/j.issn.1001-1978.2020.09.006
[7]   GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3 [J].
Geng, Lingyun ;
Lu, Kang ;
Li, Peipei ;
Li, Xinyu ;
Zhou, Xiangxiang ;
Li, Ying ;
Wang, Xin .
ONCOTARGET, 2017, 8 (30) :48701-48710
[8]   Anti-aging function and molecular mechanism of Radix Astragali and Radix Astragali preparata via network pharmacology and PI3K/Akt signaling pathway [J].
Gong, Pin ;
Wang, Danni ;
Cui, Dandan ;
Yang, Qian ;
Wang, Peipei ;
Yang, Wenjuan ;
Chen, Fuxin .
PHYTOMEDICINE, 2021, 84
[9]   High DPP4 expression predicts poor prognosis in patients with low-grade glioma [J].
Han, Yadi ;
Sun, Yuxue ;
Zhang, Yusong ;
Xia, Qingxin .
MOLECULAR BIOLOGY REPORTS, 2020, 47 (03) :2189-2196
[10]  
He Y, HAINAN MED J, V32, P246